MTOR and prostate carcinoma: Our mechanistic studies revealed that HSPB8 knockdown promoted phosphorylation of AKT and mTOR, which aligned with our speculation, i.e., the inhibitory role of HSPB8 in prostate cancer was, at least in part, linked to the inactivation of PI3K−AKT signaling pathway.